Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DICERNA PHARMACEUTICALS, INC.

(DRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on DICERNA PHARMACEUTICALS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) DICERNA PHARMACEUTICALS, INC.
Analyst Recommendations on DICERNA PHARMACEUTICALS, INC.
11/22Stifel Downgrades Dicerna Pharmaceuticals to Hold From Buy, Adjusts Price Target to $38 Fr..
MT
11/22Alnylam Pharmaceuticals Upgraded to Outperform From Sector Perform by RBC After R&D Day, P..
MT
11/19B. Riley Downgrades Dicerna Pharmaceuticals to Neutral from Buy After Announcing $3.3 Bill..
MT
11/19RBC Downgrades Dicerna Pharmaceuticals to Sector Perform From Outperform, Lifts PT to $38...
MT
11/18HC Wainwright Downgrades Dicerna Pharmaceuticals to Neutral From Buy, Adjusts PT to $38.35..
MT
08/11DICERNA PHARMACEUTICALS : B. Riley Lowers Dicerna Pharmaceuticals' PT to $35 from $49 on Heels of Revised Corporate ..
MT
08/11DICERNA PHARMACEUTICALS : Goldman Sachs Cuts Dicerna Pharmaceuticals to Neutral From Buy, Price Target to $25 From $..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Last Close Price 38,10 $
Average target price 34,96 $
Spread / Average Target -8,23%
High Price Target 38,25 $
Spread / Highest target 0,39%
Low Price Target 26,00 $
Spread / Lowest Target -31,8%
Consensus detail
Consensus revision (last 18 months)